Dr. Ron Vender gives an overview of the International Psoriasis Council Councilor Meeting at WCD2023 in Singapore.

Ritlecitinib is promising for the treatment of adults and adolescents over the age of 12 years with severe alopecia areata, according to...

More than one-third of personal care products marked as hypoallergenic at major online retailers have been found to contain common skin...

Tildrakizumab is linked to improved QoL and sleep in patients with moderate-to-severe plaque psoriasis.

In a new study, correctly-performed combined curettage and cryosurgery with standardized protocols provided excellent clinical clearance...

Exposure to biologics during pregnancy and conception does not increase the risk of adverse events in pregnant psoriasis patients.

A new study from Korea has determined that children of mothers with alopecia areata (AA) appear to be at higher risk of developing...

New findings suggest that eosinophilic cellulitis (EC) preferentially activates the Janus kinase (JAK) 1/JAK2-STAT5 pathways. The...